HK1036637A1 - Method for producing a peptide with a pl above 8 or below 5 - Google Patents

Method for producing a peptide with a pl above 8 or below 5

Info

Publication number
HK1036637A1
HK1036637A1 HK01107531A HK01107531A HK1036637A1 HK 1036637 A1 HK1036637 A1 HK 1036637A1 HK 01107531 A HK01107531 A HK 01107531A HK 01107531 A HK01107531 A HK 01107531A HK 1036637 A1 HK1036637 A1 HK 1036637A1
Authority
HK
Hong Kong
Prior art keywords
peptide
acid cleavage
fusion partner
producing
fusion
Prior art date
Application number
HK01107531A
Other languages
English (en)
Inventor
N Stephen Pollitt
Douglas I Buckley
Peter A Stathis
Taymar E Hartman
Ziyang Zhong
Original Assignee
Scios Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Inc filed Critical Scios Inc
Publication of HK1036637A1 publication Critical patent/HK1036637A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C07K1/122—Hydrolysis with acids different from HF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01028—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Cardiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Small-Scale Networks (AREA)
HK01107531A 1998-07-10 2001-10-29 Method for producing a peptide with a pl above 8 or below 5 HK1036637A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9242398P 1998-07-10 1998-07-10
PCT/US1999/015147 WO2000003011A2 (en) 1998-07-10 1999-07-08 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5

Publications (1)

Publication Number Publication Date
HK1036637A1 true HK1036637A1 (en) 2002-01-11

Family

ID=22233139

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01107531A HK1036637A1 (en) 1998-07-10 2001-10-29 Method for producing a peptide with a pl above 8 or below 5
HK07104389.4A HK1097280A1 (en) 1998-07-10 2007-04-25 Method for producing a peptide with a pl above 8 or below 5

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07104389.4A HK1097280A1 (en) 1998-07-10 2007-04-25 Method for producing a peptide with a pl above 8 or below 5

Country Status (14)

Country Link
US (1) US6303340B1 (xx)
EP (3) EP1714972B1 (xx)
JP (2) JP4741076B2 (xx)
CN (2) CN1170932C (xx)
AT (2) ATE529515T1 (xx)
AU (1) AU4859599A (xx)
CA (1) CA2334160C (xx)
CY (2) CY1106110T1 (xx)
DE (1) DE69930938T2 (xx)
DK (2) DK1714972T3 (xx)
ES (2) ES2263278T3 (xx)
HK (2) HK1036637A1 (xx)
PT (2) PT1714972E (xx)
WO (1) WO2000003011A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0854933T3 (da) * 1995-09-07 2003-07-21 Novozymes As Fagfremvisning for detergentenzym aktivitet
CN1255548C (zh) 2001-06-15 2006-05-10 霍夫曼-拉罗奇有限公司 gp41片段的乙酰化
US7771970B2 (en) 2001-07-26 2010-08-10 Advanced Protein Technologies Corporation Process for preparation of polypeptides of interest from fusion polypeptides
CA2582083A1 (en) * 2004-10-04 2006-04-20 Novetide, Ltd. A counterion exchange process for peptides
JP2008054673A (ja) * 2006-08-03 2008-03-13 Hokkaido Univ 組み換え蛋白質の製造方法
US8951185B2 (en) 2007-10-26 2015-02-10 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
US20090035815A1 (en) * 2007-06-29 2009-02-05 Laxmi Srinivas Rao Synthetic Gene for Enhanced Expression in E. Coli
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
WO2013138850A1 (en) * 2012-03-19 2013-09-26 Madeleine Pharmaceuticals Ρτy Ltd Method of producing a recombinant peptide
US20150099860A1 (en) * 2013-10-08 2015-04-09 Proteins Easy Corp Methods for separating and purifying endogenous, exogenous and recombinant proteins/peptides from plants and animals using aqueous-free, anhydrous strategies
CN106928316B (zh) * 2015-12-31 2020-11-20 深圳翰宇药业股份有限公司 一种纯化氧化含二硫键多肽的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
DK175535B1 (da) * 1987-03-04 2004-11-29 Daiichi Suntory Pharma Co Ltd Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
AU4216689A (en) * 1988-08-11 1990-03-05 California Biotechnology, Inc. Method for stabilizing heterologous protein expression and vectors for use therein
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5202239A (en) * 1990-08-07 1993-04-13 Scios Nova Inc. Expression of recombinant polypeptides with improved purification
JPH06508985A (ja) 1991-02-27 1994-10-13 クリエイティブ　バイオモレキュルズ　インコーポレイテッド 富セリンペプチドリンカー
ATE253639T1 (de) * 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden
JP3531947B2 (ja) * 1991-08-19 2004-05-31 第一サントリーファーマ株式会社 ペプチドの製造方法
US5589364A (en) 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
JP3995279B2 (ja) * 1994-09-07 2007-10-24 アスビオファーマ株式会社 蛋白の製造方法
CA2198966C (en) * 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
US5851802A (en) * 1996-03-22 1998-12-22 Xoma Corporation Methods for recombinant microbial production of fusion proteins and BPI-derived peptides

Also Published As

Publication number Publication date
DK1714972T3 (da) 2012-01-23
CN1313896A (zh) 2001-09-19
ES2263278T3 (es) 2006-12-01
DK1095141T3 (da) 2006-07-31
CN1242062C (zh) 2006-02-15
DE69930938T2 (de) 2007-01-11
EP1095141A2 (en) 2001-05-02
EP2305815A1 (en) 2011-04-06
WO2000003011A2 (en) 2000-01-20
EP1714972A3 (en) 2008-05-28
ES2374829T3 (es) 2012-02-22
CY1112195T1 (el) 2015-12-09
EP2305815B1 (en) 2014-11-05
DE69930938D1 (de) 2006-05-24
CY1106110T1 (el) 2011-06-08
CN1170932C (zh) 2004-10-13
CA2334160C (en) 2016-09-27
CA2334160A1 (en) 2000-01-20
CN1521261A (zh) 2004-08-18
JP4741076B2 (ja) 2011-08-03
US6303340B1 (en) 2001-10-16
JP5291137B2 (ja) 2013-09-18
JP2002520018A (ja) 2002-07-09
ATE323765T1 (de) 2006-05-15
HK1097280A1 (en) 2007-06-22
EP1095141B1 (en) 2006-04-19
EP1714972B1 (en) 2011-10-19
AU4859599A (en) 2000-02-01
EP1714972A2 (en) 2006-10-25
PT1095141E (pt) 2006-07-31
WO2000003011A3 (en) 2000-06-15
JP2011172575A (ja) 2011-09-08
ATE529515T1 (de) 2011-11-15
PT1714972E (pt) 2011-12-26

Similar Documents

Publication Publication Date Title
HK1097280A1 (en) Method for producing a peptide with a pl above 8 or below 5
DE69433010D1 (de) Verfahren zur darstellung von oligonukleotiden
WO2001079459A3 (en) Polypeptides having haloperoxidase activity
AU3899799A (en) Method for the production of 1,3-propanediol by recombinant organisms comprisinggenes for vitamin b12 transport
WO1996017924A3 (en) Novel hedgehog-derived polypeptides
HUT75261A (en) Process for producing 1-hydroxy-alkylidene-1,1-bisphosphonic acids and intermediates thereof, trimers and tetramers of alkylpyrophosphonate and alkylpyrophosphate as intermediates
WO2004015085A3 (en) Method and compositions relating to 5’-chimeric ribonucleic acids
AU8202098A (en) Method for improving the freezing tolerance of plants
AU5155996A (en) Control of pod dehiscence
CA2257115A1 (en) Spruce budworm antifreeze proteins, genes and methods of using same
AU3711597A (en) A novel galanin receptor
ES2144698T3 (es) Procedimiento para preparar un derivado de biciclohexano.
WO2002081622A3 (en) Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
DE69611924D1 (de) Verfahren zur herstellung von mangansulfid
SI1401871T1 (xx)
AU6468099A (en) Accelerator for the production of polyamides from aminonitriles
WO2004007668A3 (en) Improved transporters and their uses
EP1410720A4 (en) PROCESS FOR PRODUCING FROZEN "YUBA"
AU3140299A (en) Method to prepare alpha-beta unsaturated carboxylic acids
AU4494599A (en) Method for genetic engineering of disease resistance using the drr206 class of proteins
WO1998024894A3 (de) Pkd1-fragmente mit bindungsregionen für pkd1-spezifische antikörper
PL364939A1 (en) Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters
WO1999042621A3 (en) Methods for identifying or characterising a site based on the thermodynamic properties of nucleic acids
AU1152699A (en) S-(4-biphenyl)-thiosulphuric acids and their salts, method for producing the same and method for producing 4-mercaptobiphenyls
AU1801699A (en) Creation of heteroimmunity amongst ctx$g(f): methods and compounds for the construction of improved (v. cholerae) vaccines

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190707